FBXO39
F-box only protein 39
Also known as: CT144, Fbx39, FBX39_HUMAN, MGC35179
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N4B4
- Gene
- FBXO39
- Ensembl
- ENSG00000177294
- Chromosome
- 17
- Canonical length
- 442 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Members of the F-box protein family, such as FBXO39, are characterized by an approximately 40-amino acid F-box motif. SCF complexes, formed by SKP1 (MIM 601434), cullin (see CUL1; MIM 603134), and F-box proteins, act as protein-ubiquitin ligases. F-box proteins interact with SKP1 through the F box, and they interact with ubiquitination targets through other protein interaction domains (Jin et al., 2004 [PubMed 15520277]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
442 residues, UniProt reviewed canonical sequence.
>Q8N4B4|FBXO39
1 MDEESELIQP QDQSCWAFLP DLCLCRVFWW LGDRDRSRAA LVCRKWNQMM YSAELWRYRT
61 ITFSGRPSRV HASEVESAVW YVKKFGRYLE HLEVKFMNPY NAVLTKKFQV TMRGLLSCLS
121 KSNNRLKSLS IQYLELDRLV WRNSIRSSFI SSLSFFLKKM GKRLDYLNLK GARLTVEQGC
181 QILDSLSYMR NENVISELNI EDYFSHHLAV YNSPQFKKTM STFHNLVSLN LNYNCISDEL
241 LENLCENAST LRTINIKCHV HDPHGQVIWG MSWAKLARQA TNLKVNFFFE RIMKYERLAR
301 ILLQEIPIRS ISLRSCYFSD PDCSMRPTLI DLLPTFRHTL QKLTCEFNNN HESLDEELHL
361 LIISCRKLFY FKIWAFLDVS FVERILKSQK ERQCALRVFK ARIYTNRYET NEEDKTLQEI
421 YRKYRKLIES ELSYFVIVYS VMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FBXO39 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- testis: 29 nTPM
- ovary: 1 nTPM
- liver: 0.8 nTPM
- cervix: 0.4 nTPM
- adipose tissue: 0.3 nTPM
- fallopian tube: 0.3 nTPM
Single-cell type
- late spermatids: 727 nCPM
- early spermatids: 542 nCPM
- late primary spermatocytes: 19 nCPM
- thymocytes: 15 nCPM
- vascular endothelial cells: 6.8 nCPM
- leydig cells: 5.4 nCPM
Immune cell
- gdT-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 0.9 nTPM
- medulla oblongata: 0.9 nTPM
- midbrain: 0.6 nTPM
- spinal cord: 0.6 nTPM
- amygdala: 0.5 nTPM
- basal ganglia: 0.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FBXO39.
Disease | ImmuneIEDB
Conditions an epitope on FBXO39 was assayed in.
- colon adenocarcinoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.06
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FBXO39 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FBXO39 as an antibody target. Whether an autoantibody or antibody against FBXO39 could matter depends on whether native FBXO39 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FBXO39 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FBXO39 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...